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Abstract
Background: The aim of this work was to study the ultrasonographic (USG) features of knee joints in relation to clinical and laboratory 
measures in patients with juvenile rheumatoid arthritis (JRA), and also to evaluate the accuracy of ultrasound in the diagnosis of local 
joint activity.
Methods: This study included 20 with JRA and 20 matched and apparently healthy controls. All patients were subjected to full history 
taking, careful clinical examination and laboratory investigation. The knee joints of all patients and control were examined with plain 
radiography and ultrasonography on the same day of clinical examination using ultrasound to detect synovial thickness and effusion 
at the knee.
Results: Mean USG knee synovial thickness was significantly greater in JRA patients versus controls (4.2 ± 2.4 mm versus 1.7 ± 0.3 mm, 
P , 0.001). Although knee effusion was not detected in any of the controls, it was demonstrated in 90% of JRA patients, with a mean 
effusion volume of 3.8 ± 3.1 mL. There was a statistically significant difference (P , 0.001) between clinically active and inactive knees 
with regard to knee synovial thickness. Mean knee effusion volume was significantly (P , 0.05) higher in the clinically active than in 
the clinically inactive knees. Patients with high disease activity had a significantly (P , 0.05) higher knee synovial thickness and knee 
effusion volume than patients with low and moderate disease activity. Significantly (P , 0.05) positive correlations were found between 
knee synovial thickness and articular index (AI) scores, disease activity score, clinical knee scores, erythrocyte sedimentation rate 
(ESR), and C-reactive protein (CRP) levels. Significant positive correlations (P , 0.05) were found between knee effusion volume and 
AI scores, visual analog scores, disease activity scores, clinical knee scores, ESR, and CRP levels. Significant negative correlations 
(P , 0.05) were found between knee effusion volumes and hemoglobin levels.
Conclusion: UGS-detected parameters represent a reliable index of JRA disease activity with a higher sensitivity for knee synovial 
thickness and higher specificity for knee effusion.
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Introduction
Juvenile  rheumatoid  arthritis  (JRA)  is  a  chronic 
multisystem  inflammatory  disease  with  prominent 
joint manifestation.1 It is the most common rheumatic 
disease of childhood.2 The knee is the most commonly 
affected joint in JRA, and overall accounts for the 
most  disability.3  Clinical  parameters  in  the  early 
stages of the disease have been shown to be very use-
ful  for  predicting  the  articular  outcome  of  JRA. 
Therefore, they could constitute a good instrument to 
help clinicians tailor the best therapy for their patients.4 
Clinical evaluation of symptomatic joints is frequently 
supplemented  with  plain  radiographs.  However, 
radiographic changes mostly represent late and indi-
rect signs of rheumatic disease.5
In addition, early detection of joint involvement 
would allow the treating doctor to intervene at the 
appropriate time and prescribe suitable medication.6 
Based on these facts and on the limitation of plain 
radiographs for detecting radiological changes, there 
is a real need for other radiological variables to assess 
the joints in patients with arthritis.7
Ultrasonography (USG) has considerable advan-
tages over other imaging methods, including nonin-
vasiveness, speed of performance, relatively low cost, 
ability to scan multiple joints, repeatability, and high 
patient acceptability.8 The aim of this work was to 
study the USG features of the knee joints in patients 
with JRA, to correlate these features with clinical and 
laboratory parameters of JRA, and to evaluate the 
accuracy of USG in the diagnosis of local joint activ-
ity in JRA.
Methods
This study included 20 patients fulfilling the criteria 
of Cassidy et al9 for the diagnosis of JRA (Group 1) as 
well  as  20  apparently  healthy  age-  and  gender-
matched children as controls (Group 2). Patients in 
Group 1 comprised nine males (45%) and 11 females 
(55%), whose mean age was 9.2 ± 3.9 years, with 
a  mean  disease  duration  of  39.1  ±  32.4  months. 
Eight  patients  (40%)  had  polyarticular  onset  JRA, 
seven patients (35%) had pauciarticular onset, and 
five  patients  (25%)  had  systemic  onset  JRA. 
All  patients  were  subjected  to  full  history  taking, 
clinical  examination  with  stress  of  the  locomotor 
  system,  and  the  following  measurements  were 
recorded: Ritchie articular index score for assessing 
joint  tenderness,10  clinical  assessment  of  the  knee 
according to Sureda et al,11 including presence of pain 
(score  1  or  absence  score  0),  degree  of  swelling 
(score  0  absence,  score  1  mild,  score  2  moderate, 
score 3 severe), degree of limitation of extension (no 
limitation score 0, ,5° limitation of extension score 1, 
,10° limitation of extension score 2, ,15° limitation 
of extension score 3, .15° limitation of extension 
score 4). Patients with a mean total score $1 were 
classified as having active knee involvement, while 
patients with normal physical findings were consid-
ered to be in clinical remission. Functional capacity 
of the patients was assessed using the Steinbrocker 
grading system12 and the juvenile arthritis functional 
assessment report (JAFAR) according to Lovell et al.13 
Clinical assessment of disease activity was performed 
using the modified disease activity score of 28 joint 
count (DAS 28). DAS is a statistically derived index 
consisting  of  number  of  tender  joints,  number  of 
swollen  joints,  erythrocyte  sedimentation  rate,  and 
global  disease  activity.14  Laboratory  investigations 
were performed for all patients, including determina-
tion of hemoglobin concentration (g/dL), erythrocyte 
sedimentation rate by Westergrens method,   C-reactive 
protein detection by the latex agglutination slide test, 
and  rheumatoid  factor  slit  lamp  for  antinuclear 
  antibodies. Conventional radiological examination of 
the knee joint in the anteroposterior and lateral pro-
jections were obtained on the same day as the ultra-
sound examination. USG was done for both knees of 
all patients and controls on the same day as the clini-
cal  and  laboratory  investigation  using  the  Megas 
Esaote SpA with a 7.5 mHz linear probe and color 
Doppler. Knee ultrasound was obtained by sets of 
sagittal images of the suprapatellar bursa with the 
patient  in  the  recumbent  position  and  the  knee  in 
30% flexion. A standardized procedure similar to that 
used previously by other investigators11 was followed. 
The ultrasound transducer was positioned longitudi-
nally above the patella, and the synovial thickness 
was measured when the probe touched the middle 
portion of the basis patella, measurement of total syn-
ovial thickness (with electronic calipers and corre-
sponding to the largest anteroposterior diameter of 
the suprapatellar pouch) was performed by applying 
firm compression with the transducer to express the Ultrasound assessment in juvenile rheumatoid arthritis
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suprapatellar fluid into the joint recesses. Assessment 
of intra-articular fluid was performed by measuring 
the  length  of  the  suprapatellar  bursa.  Longitudinal 
images were obtained with manual compression of the 
lateral synovial recesses to express all intra-articular 
fluid into the suprapatellar bursa. Transverse diame-
ters were also obtained for the longitudinal images, 
followed  by  depth  measurements  in  the  transverse 
images. The volume of fluid was then calculated.
Results
Table  1  shows  the  clinical,  laboratory,  and  USG 
characteristics of the 20 JRA patients. In our study, 
clinical  knee  joint  involvement  was  present  in 
15 patients (75%) of 20 patients examined (Table 1). 
Six patients (40%) had polyarticular onset disease, 
five patients (33.3%) had pauciarticular onset, and 
four  patients  (26.7%)  had  systemic  onset  disease. 
Bilateral  knee  joint  involvement  was  found  in 
11  patients  (73.3%),  while  unilateral  involvement 
was  found  in  four  patients  (26.7%).  Clinical  knee 
joint involvement was observed in 26 of the 40 knees 
examined.
Mean ± standard deviation (SD) USG knee syn-
ovial thickness was 4.2 ± 2.4 mm in the JRA patients 
and 1.7 ± 0.3 mm in the control group. This differ-
ence  was  statistically  significant  (P  ,  0.001). 
Although knee effusion was not detected in any of 
the control subjects, it was demonstrated in 90% of 
the JRA patients, with a mean effusion volume of 
3.8 ± 3.1 mL (Figure 1 and 2).
In the JRA patients, mean knee synovial thickness 
was 5.2 ± 2.3 mm in the clinical active knees and 
2.3 ± 1.0 mm in the clinically inactive knees. This dif-
ference  was  statistically  significant  (P  ,  0.001). 
Mean USG knee effusion volume was significantly 
higher  in  clinically  active  knees  than  in  clinically 
inactive knees (4.8 ± 3.6 mL and 2.0 ± 0.9 mL, respec-
tively, P , 0.05).
There  was  a  highly  statistically  significant 
(P , 0.001) difference in levels of C-reactive protein 
and erythrocyte sedimentation rate between patients 
with low, moderate, and high disease activity, being 
highest in the first hour in those with high disease 
activity  (60.9  ±  15.6  mm  and  50.3  ±  24.6  mg/L, 
respectively).  There  was  a  statistically  significant 
(P , 0.05) difference between patients for articular 
index  score  and  JAFAR  scores,  being  highest  in 
patients with high disease activity (25.9 ± 11.0 and 
11.1 ± 4.9, respectively). Patients with high disease 
activity had significantly (P , 0.05) lower hemoglo-
bin levels (9.4 ± 1.0 g/dL).
There was no significant difference for disease 
duration, visual analog score, or clinical knee score. 
Patients  with  high  disease  activity  had  a  signifi-
cantly  (P  ,  0.05)  greater  USG  knee  synovial 
Table 1. Clinical, laboratory, and ultrasonographic characteristics of 20 patients with juvenile rheumatoid arthritis.
Age, years, mean ± SD (range) 9.2 ± 3.9 (4–16)
gender, male/female (%) 9/11 (45%–55%)
Disease onset (%) Pauci/poly/syst 7/8/5 (35%/40%/25%)
Disease duration/months, mean ± SD (range) 39.1 ± 32.4 (7−120)
Articular index, mean ± SD 16.4 ± 10.6
Visual analog scale (cm), mean ± SD 5.1 ± 1.9
Disease activity score, mean ± SD 4.0 ± 1.1
Functional capacity grading (%) 1/2/3 8/8/4 (40%/40%/20%)
JAFAr score, mean ± SD 8.4 ± 4.4
Clinical knee score, mean ± SD 2.7 ± 2.5
hemoglobin (g/dL), mean ± SD 10.0 ± 1.4
eSr level (mm/hour), mean ± SD 47.2 ± 17.5
CrP level (mg/L), mean ± SD 29.2 ± 20.9
rheumatoid factor (%) 5 positive/15 negative (25%−75%)
USg knee synovial thickness (mm), mean ± SD 4.2 ± 2.4
USg knee effusion volume (mL), mean ± SD 3.8 ± 3.1
Abbreviations:  JAFAr,  juvenile  arthritis  functional  assessment  report;  eSr,  erythrocyte  sedimentation  rate;  CrP,  C-reactive  protein;  USg, 
ultrasonographic; SD, standard deviation; syst, systemic; poly, polyarticular; pauci, pauciarticular.Algergawy et al
24  Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 2011:4
thickness (6.7 ± 1.7 mm) and USG knee effusion 
volume (7.9 ± 5.2 mL) than patients with low or 
moderate disease activity.
Patients with functional capacity Grade 3 had had a 
significantly (P , 0.001) longer mean disease duration 
(60.3 ± 25.4 months) and significantly (P , 0.005) 
higher mean JAFAR score (12.4 ± 3.7) than patients 
with  Grade  1  and  Grade  2  functional  capacity. 
There was statistically significant difference between 
the patients with Grade 1, 2, and 3 functional capacity 
with  regard  to  articular  index  score,  visual  analog 
score,  DAS  score,  clinical  knee  score,  hemoglobin 
level,  erythrocyte  sedimentation  rate,  C-reactive 
  protein, USG knee synovial thickness, or USG knee 
effusion volume.
From our calculations, the upper limit of normal 
value (cutoff point) for USG knee synovial thickness 
was 2.3 mm, recorded as the mean for controls + 2 SD. 
In  our  study,  26  of  the  40  knees  examined  were 
  clinically  active.  Twenty-five  of  the  26  clinically 
active  knees  showed  pathological  USG  synovial 
thickness  .2.3  mm.  Seven  clinically  inactive 
knees  showed  USG  pathological  synovial 
thick  ness .2.3 mm. Two control knees showed USG 
pathological  thickness  .2.3  mm.  These  results 
yielded a sensitivity of 82.5% and a specificity of 
95%,  a  positive  predictive  value  of  94.3%,  and  a 
  negative predictive value of 84.4%. None of our con-
trol  subjects  showed  intra-articular  knee  effusion, 
whereas USG knee effusion was detected in 90% of 
our JRA patients, indicating 100% specificity of ultra-
sound in detecting effusion in clinically active joints.
Discussion
JRA is one of the most common inflammatory dis-
eases of childhood and is a major cause of disability.15 
Several  clinical  studies  done  in  patients  with  JRA 
have shown that the knee is the joint most frequently 
affected.16 History-taking and physical examination 
supplemented  with  radiological  investigation  are 
the  usual  tools  to  make  the  diagnosis  of  JRA.17 
  Radiographic changes mostly represent late and indi-
rect signs of synovial disease.18
Over  the  past  few  years,  rheumatologists  have 
become increasingly interested in detection of syno-
vitis and bony erosions in both small and large joints.19 
It has several advantages over magnetic resonance 
imaging, including cost, immediate availability in the 
clinic,  and  the  ability  to  scan  multiple  joints 
simultaneously.20,21 The demographic characteristics 
of  our  patients  were  similar  to  those  reported  by 
Fedrizzi et al,22 whose study comprised 35 patients 
with JRA of mean age nine (2–16) years. Their dis-
ease  duration  ranged  between  six  months  and  11 
years, with a mean duration of three years. Systemic 
onset was documented in 17% of patients, polyarticu-
lar onset in 34%, and pauciarticular onset in 49%. 
Our clinical data are also consistent with those of 
Argyropoulou et al.23 Their study included 28 patients 
with JRA, comprising 13 patients (46.5%) with pol-
yarticular  onset,  eight  (28.5%)  with  pauciarticular 
onset, and seven (25%) with systemic onset. In our 
study, clinical knee joint activity was present in 15 
(75%)  of  20  patients  examined  (26  of  40  knees). 
Bilateral  knee  joint  involvement  was  found  in 
11  patients  (73.3%),  while  unilateral  involvement 
was found in four patients (26.7%). Of 15 patients, 
six (40%) had polyarticular onset, five (33.3%) had 
pauciarticular onset, and four (26.7%) had systemic 
onset disease. El Miedany et al3 stated that the knee is 
the joint most frequently affected. In our study, we 
examined the knees by USG for detection of both 
synovial thickness and effusion volume, and found a 
mean USG synovial thickness of the knee joints in 
JRA patients of 4.2 ± 2.4 mm which was significantly 
(P , 0.001) higher than the mean value of 1.7 ± 0.3 
recorded in our control subjects. These results are 
consistent with those reported by Sureda et al,11 for 36 
children with JRA and 30 healthy controls. They found 
that mean synovial thickness of the knee joint was 
Figure 1. Ultrasound of the right knee joint (ventral longitudinal scan of 
suprapatellar pouch) showing normal knee synovial thickness. note that 
no effusion is detected.
Abbreviations: P, patella; Fh, femoral head.Ultrasound assessment in juvenile rheumatoid arthritis
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significantly (P , 0.001) greater in patients with JRA 
than in the controls (5.2 ± 3 mm versus 2.7 ± 0.8 mm, 
respectively).
Our results differ slightly from those of Barbuti 
et al,24 who investigated the role of USG in follow-up 
of the knee joint, and undertook 594 examinations in 
240 children with JRA, reporting a mean synovial 
thickness of 6 mm (range 2.5–11) mm in JRA patients 
with affected knees compared with a mean synovial 
thickness  of  2.7  (range  1.0–4.5)  mm  in  normal 
  subjects. This variability of synovial thickness results 
could be attributed to the large number of patients 
examined in their study. Our results also relatively 
close to those of EL-Miedany and his colleagues,3 
who  studied  the  ultrasound  versus  magnetic  reso-
nance imaging in evaluating the knee joint in patients 
with JRA. They reported that the synovial thickness 
of the knee joint was significantly increased in patients 
with JRA, with a mean of 5.2 ± 2.5 mm on both 
ultrasound  and  magnetic  resonance  imaging,  com-
pared with a mean thickness of 2.7 mm ± 0.8 mm in 
the  control  group.  the  authors  also  stated  that,  in 
healthy children, visualization of the synovial mem-
brane may be difficult because it is extremely thin and 
has echogenicity similar to that of the surrounding 
tissue. In our study, there was a highly statistically 
significant  difference  (P  ,  0.001)  between  the 
mean  USG  synovial  thickness  of  clinically  active 
(5.2  ±  2.3  mm)  and  clinically  inactive  knees 
(2.3 ± 1 mm). There was also a statistically significant 
(P , 0.05) difference in the mean USG knee synovial 
thickness  between  patients  with  JRA  according  to 
their disease activity score, being greatest in those 
with a high activity score (Grade 3) who had a mean 
thickness of 6.0 ± 1.7 mm. This agrees with work 
done by Cellerinui et al,25 who found a statistically 
significant (P , 0.001) increase in the mean USG 
synovial  thickness  of  clinically  active  knee  joints 
  versus  clinically  silent  joints.  Our  finding  contrast 
with those reported by Frosch et al,26 who did not find 
a significant difference in either the number of patients 
with synovial thickness or the mean synovial thick-
ness between clinically active and inactive arthritis at 
follow-up examinations. In their study, the volume of 
fluid in the suprapatellar bursa in JRA knees ranged 
between 2.4 ± 15 mL, with a mean of 3.8 ± 3.1 mL. 
Sureda et al11 reported similar findings whereby ultra-
sound  could  not  detect  knee  effusion  in  healthy 
  children and demonstrated effusion in 60% of docu-
mented  clinically  active  knees.  In  their  study,  the 
length of the suprapatellar bursa was measured rather 
than the volume of the effusion. Also El-Miedany 
et al3 detected mild to moderate joint effusion in 18 
out of 38 cases of JRA by assessment of the length of 
the suprapatellar bursa. Frosch et al26 found a marked 
effusion within the suprapatellar pouch by measuring 
the largest anterioposterior diameter of the suprapa-
tellar pouch in mm. In our study, we measured the 
length, width, and depth of the bursa to determine the 
actual  volume  of  the  effusion  in  the  suprapatellar 
bursa. We assumed that this would be a more accurate 
  assessment  method,  especially  after  noticing  the 
  variability  in  the  depth  and  width  of  the  bursa. 
  Comparing the mean USG knee effusion volume in 
our  JRA  patients  according  to  their  local  disease 
activity, we found a significant increase (P , 0.05) in 
mean USG effusion in active knees compared with 
inactive knees. This finding is in agreement with that 
of Cellerini et al25 who reported a statistically signifi-
cant  increase  in  articular  effusion  from  clinically 
active knee joints versus clinically silent joints. This 
also coincides with a study done with Forsch et al26 
who found a highly significant (P , 0.001) difference 
in the number of patients with joint effusion as well 
as in the mean USG joint effusion volume between 
Table  2.  Correlation  coefficients  between  clinical  and 
  laboratory variables of patients with juvenile rheumatoid 
arthritis in relation to their ultrasonographic findings.
UsG knee  
synovial  
thickness 
UsG knee   
effusion  
volume
Disease duration (month) 0.18 0.23
AI score 0.74* 0.64*
VAS (cm) 0.21 0.41*
DAS score 0.73* 0.83*
JAFAr score 0.13 0.37
Clinical knee score 0.71* 0.85*
Clinical hip score 0.23 0.15
hb level (gm/dL) −0.31 −0.81*
ESR level (mm first hour) 0.61* 0.44*
CrP level (mg/L) 0.51* 0.45*
notes: Critical value(r) = 0.9; P . 0.05 insignificant; P , 0.05* = significant.
Abbreviations: AI, articular index; DAS, disease activity score; VAS, 
visual  analog  scale;  JAFAr,  juvenile  arthritis  functional  assessment 
record; hb, hemoglobin level; eSr, erythrocyte sedimentation rate; CrP, 
C-reactive protein; USg, ultrasonography.Algergawy et al
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patients  with  clinically  active  and  inactive  knee 
  arthritis at follow-up examinations. In our study, there 
was  a  significant  positive  correlation  (P  ,  0.05), 
between mean USG synovial thickness of the knee 
and the clinical knee scores (r = 0.71), articular indi-
ces (r = 0.74), DAS (r = 0.73), erythrocyte sedimenta-
tion  rate  (r  =  0.61),  and  C-reactive  protein  levels 
(r = 0.5). There was also a significant positive correla-
tion (P , 0.05) between mean USG knee effusion 
volumes  and  articular  indices  (r  =  0.64),  VAS 
(r  =  0.41),  DAS  (r  =  0.83),  clinical  knee  scores 
(r = 0.85), erythrocyte sedimentation rate (r = 0.44) 
and C-reactive protein levels (r = 0.45). This coin-
cides with the findings of Frosch et al26 who found a 
strong  positive  significant  correlation  (P  ,  0.001) 
between  sonographic  parameters,  especially  joint 
effusion,  and  the  clinical  findings  of  knee  joint 
  examination.  With  regard  to  USG  knee  synovial 
thickness, we found a sensitivity of 82.5%, a specific-
ity of 95%, a positive predictive value of 94.3%, and 
a negative predictive value of 84.4%. For knee joint 
effusion, none was detected in the control group, but 
it  was  detected  in  90%  of  the  patients,  indicating 
100% specificity of ultrasound for detecting effusion 
in clinically active joints. This coincides with a report 
by Cellerini et al,25 who commented that ultrasound is 
particularly sensitive in the detection of synovial effu-
sion and its differentiation from synovial thickness. 
In their study, ultrasound demonstrated effusion and 
synovial thickness in 70% of clinically silent joints. 
This  is  also  in  agreement  with  the  findings  of  El 
Miedany et al,3 who found mild to moderate effusion 
on ultrasound in 18 of 38 cases (47%), and confirms a 
report by Kaye et al27 who stated that ultrasound is a 
sensitive method for detecting the presence of small 
suprapatellar   effusion. A prospective study is recom-
mended to assess whether USGs finding could be pre-
dictive of early relapse in order to treat a silent joint, 
as long as diagnosis and   therapy is routinely estab-
lished on a clinical basis.
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